Atrial fibrillation (AF) is the most common arrhythmia diagnosed in clinical practice. The
consequences of AF have been clearly established in multiple large observational cohort …

Background Four direct oral anticoagulants (DOACs) have been brought to market for the
treatment of nonvalvular atrial fibrillation and venous thromboembolism. Many forces …

Atrial fibrillation (AF) is the most common cardiac arrhythmia worldwide and is a growing
health problem that is associated with a significantly increased risk of stroke and …

Background Only 50% of atrial fibrillation (AF) patients recommended for oral
anticoagulation (OAC) use these medications, and less than half of them adhere to OAC. In …

Background: Left atrial appendage closure (LAAC) and nonwarfarin oral anticoagulants
(NOACs) have emerged as safe and effective alternatives to warfarin for stroke prophylaxis …

Background In patients with atrial fibrillation, incomplete adherence to anticoagulants
increases risk of stroke. Non-warfarin oral anticoagulants (NOACs) are expensive; we …

Abstract Background The World Heart Federation has undertaken an initiative to develop a
series of Roadmaps to promote development of national policies and health systems …

Aims We aimed to assess the impact of an educational, motivational intervention on the
adherence to oral anticoagulation (OAC) in patients with non-valvular atrial fibrillation (AF) …

Background. Circular RNA (circRNA) is a noncoding RNA that forms a closed‐loop structure,
and its abnormal expression may cause disease. We aimed to find potential network for …

Introduction The objective of this study was to compare the risk of stroke in atrial fibrillation
(AF) with adherent use of oral anticoagulation (OAC), non-adherent use, and non-use of …